Business Description
Fagron SA
ISIN : BE0003874915
Total Employee Number:
4,297Compare
Compare
Traded in other countries / regions
FAGR.Belgium0HNZ.UK4A5.GermanyFAGR.NetherlandsARSUF.USA IPO Date
2007-10-05Description
Fagron SA is a Belgium-based multinational pharmaceutical compounding company specializing in pharmaceutical compounding. It operates across the pharmaceutical compounding value chain, developing and manufacturing personalized medicines in collaboration with pharmacists, prescribers, hospitals, and other healthcare providers. The company has three segments: Essentials, Brands, and Compounding Services. The majority of the revenue is derived from the Essentials segment, which provides raw materials, equipment, packaging, and supplies for compounding to pharmacies and healthcare industries across EMEA, Latin America, and North America - Pacific. Geographically, it generates the maximum revenue from Fagron North America - Pacific.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.4 | |||||
Equity-to-Asset | 0.44 | |||||
Debt-to-Equity | 0.85 | |||||
Debt-to-EBITDA | 2.58 | |||||
Interest Coverage | 7.44 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.26 | |||||
Beneish M-Score | -2.62 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.5 | |||||
3-Year EBITDA Growth Rate | 11.7 | |||||
3-Year EPS without NRI Growth Rate | 9.9 | |||||
3-Year FCF Growth Rate | 10.9 | |||||
3-Year Book Growth Rate | 10.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 14.62 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 10.73 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.11 | |||||
Quick Ratio | 1.39 | |||||
Cash Ratio | 0.84 | |||||
Days Inventory | 104.11 | |||||
Days Sales Outstanding | 34.9 | |||||
Days Payable | 86.08 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Payout Ratio | 0.28 | |||||
3-Year Dividend Growth Rate | 20.5 | |||||
3-Year Average Share Buyback Ratio | -0.2 | |||||
Shareholder Yield % | -1.83 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 45.37 | |||||
Operating Margin % | 15.49 | |||||
Net Margin % | 9.56 | |||||
EBITDA Margin % | 19.05 | |||||
FCF Margin % | 13.09 | |||||
OCF Margin % | 16.31 | |||||
ROE % | 17.57 | |||||
ROA % | 7.92 | |||||
ROIC % | 13.82 | |||||
3-Year ROIIC % | 21.34 | |||||
ROC (Joel Greenblatt) % | 54.99 | |||||
ROCE % | 14.61 | |||||
Years of Profitability over Past 10-Year | 9 | |||||
Moat Score | 5 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 19.15 | |||||
Forward PE Ratio | 4.35 | |||||
PE Ratio without NRI | 18.95 | |||||
Shiller PE Ratio | 28.61 | |||||
Price-to-Owner-Earnings | 16.56 | |||||
PEG Ratio | 1.84 | |||||
PS Ratio | 1.82 | |||||
PB Ratio | 3.15 | |||||
Price-to-Free-Cash-Flow | 13.95 | |||||
Price-to-Operating-Cash-Flow | 11.2 | |||||
EV-to-EBIT | 14.93 | |||||
EV-to-EBITDA | 11.31 | |||||
EV-to-Revenue | 2.16 | |||||
EV-to-FCF | 16.29 | |||||
Price-to-GF-Value | 0.99 | |||||
Price-to-Projected-FCF | 1.14 | |||||
Price-to-Median-PS-Value | 1 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.84 | |||||
Earnings Yield (Greenblatt) % | 6.69 | |||||
FCF Yield % | 7.07 | |||||
Forward Rate of Return (Yacktman) % | 15.13 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Fagron SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 952.169 | ||
| EPS (TTM) (€) | 1.24 | ||
| Beta | 0.1052 | ||
| 3-Year Sharpe Ratio | -46.21 | ||
| 3-Year Sortino Ratio | -3.45 | ||
| Volatility % | 6.23 | ||
| 14-Day RSI | - | ||
| 14-Day ATR (€) | - | ||
| 20-Day SMA (€) | 6.41714 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 6.41714 - 6.41714 | ||
| Shares Outstanding (Mil) | 73.35 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Fagron SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Fagron SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| EUR 0.400000 Cash Dividend | 2026-05-18 | 6.42 (+0.00%) | ||
| EUR 0.350000 Cash Dividend | 2025-05-19 | 6.42 (+0.00%) |
Show
Entries
Fagron SA Frequently Asked Questions
What is Fagron SA(XAMS:FAGR)'s stock price today?
The current price of XAMS:FAGR is €6.42. The 52 week high of XAMS:FAGR is €6.42 and 52 week low is €6.42.
When is next earnings date of Fagron SA(XAMS:FAGR)?
The next earnings date of Fagron SA(XAMS:FAGR) is .
Does Fagron SA(XAMS:FAGR) pay dividends? If so, how much?
Fagron SA(XAMS:FAGR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Fagron SA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers